Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

Abstract Non-alcoholic steatohepatitis (NASH) is a major health problem leading to liver fibrosis and hepatocellular carcinoma, among other diseases, and for which there is still no approved drug treatment. Previous studies in animal models and in LX-2 cells have indicated a role for serotonin (5-HT...

Bibliografske podrobnosti
Main Authors:	Sara Redenšek Trampuž, Sander van Riet, Åsa Nordling, Magnus Ingelman-Sundberg
Format:	Article
Jezik:	English
Izdano:	Nature Portfolio 2024-01-01
Serija:	Scientific Reports
Online dostop:	https://doi.org/10.1038/s41598-023-49240-9

Podobne knjige/članki

The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
od: Sara Redenšek Trampuž, et al.
Izdano: (2023-01-01)

The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model
od: Sander van Riet, et al.
Izdano: (2024-03-01)

Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
od: Tracey Hurrell, et al.
Izdano: (2020-04-01)

Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
od: Chris S. Pridgeon, et al.
Izdano: (2022-05-01)

Azologization of serotonin 5-HT3 receptor antagonists
od: Karin Rustler, et al.
Izdano: (2019-03-01)

Existence of Brain 5‑HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5‑HT1A Receptor Recognition
od: Dasiel O. Borroto-Escuela, et al.
Izdano: (2017-08-01)

Effects of 5‐HT₃ receptor antagonists on cisplatin‐induced kidney injury
od: Mitsuhiro Goda, et al.
Izdano: (2021-09-01)

How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties?
od: Abbas Norouzi, et al.
Izdano: (2012-04-01)

How Can 5-HT3 Receptor Antagonists Exert Analgesic Properties?
od: Reza Rahimian, et al.
Izdano: (2012-04-01)

Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists
od: Gilmore J, et al.
Izdano: (2018-07-01)

Constitutively active 5-HT receptors: An explanation of how 5-HT antagonists inhibit gut motility in species where 5-HT is not a enteric neurotransmitter ?
od: Nick eSpencer
Izdano: (2015-12-01)

Antiemetic Activity of FK1052, a 5-HT3- and 5-HT4-Receptor Antagonist, in Suncus murinus and Ferrets
od: Hiroe Nakayama, et al.
Izdano: (2005-01-01)

Studies on the role of 5-HT2A and 5-HT2C receptor antagonist and effects of co-administration of Fluoxetines in regulating generalized seizures in albino rats
od: Vasant R Chavan, et al.
Izdano: (2010-07-01)

Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor
od: Habib Abul Muntasir, et al.
Izdano: (2006-01-01)

5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra.
od: Threlfell, S, et al.
Izdano: (2010)

Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis.
od: Dian J Chiang, et al.
Izdano: (2013-01-01)

The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.
od: Roberts, J, et al.
Izdano: (2002)

THE ANTIEMETIC ACTION OF THE NOVEL 5-HT3 RECEPTOR ANTAGONIST L-683,877 IN THE FERRET
od: Tattersall, F, et al.
Izdano: (1990)

ANTAGONIST EFFECT OF MDL-73005EF ON POSTSYNAPTIC 5-HT1A RECEPTORS IN THE RAT
od: Gartside, S, et al.
Izdano: (1990)

Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
od: Boothman, L, et al.
Izdano: (2006)

Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists
od: Heng, Hui Li, et al.
Izdano: (2018)

Automated Synthesis of 5-HT1A Receptors Antagonists 11C-WAY-100635
od: LI Hui-qiang1,2;ZHEN Zhi-fei1;ZHANG Wei-feng1;LIAO Shu-guang1;LI Hong-li3;XU Jun-ling1,2
Izdano: (2017-02-01)

3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists
od: Antonijević Mirjana, et al.
Izdano: (2017-01-01)

Serotonin (5-HT3) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
od: Itagaki R, et al.
Izdano: (2014-03-01)

5-HT3 Receptor Antagonists: New Promising Therapeutic Agents in Diabetes and Its Complications
od: Reza Rahimian, et al.
Izdano: (2013-10-01)

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
od: Nazanin Aboulghasemi, et al.
Izdano: (2019-06-01)

Combination of Direct DNA Sequencing with Degenerate Primer-Mediated PCR and 5′-/3′-RACE to Screen Novel cDNA Sequences
od: Che Fang, et al.
Izdano: (1997-07-01)

Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress
od: Hyun Young Kim, et al.
Izdano: (2024-06-01)

The Human Cytochrome P450 (<it>CYP</it>) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects
od: Sim Sarah C, et al.
Izdano: (2010-04-01)

Intronic polymorphisms of cytochromes P450
od: Ingelman-Sundberg Magnus, et al.
Izdano: (2010-08-01)

Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
od: Corbett, D, et al.
Izdano: (2005)

Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
od: Hughes, Z, et al.
Izdano: (2007)

Efficacy of 5-HT3 receptor antagonists (ondansetron) vs dopamine receptor antagonists (droperidol) for preventing postoperative nausea, vomiting and headache: a meta-analysis
od: Chen Xiaoyun, et al.
Izdano: (2019-07-01)

Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.
od: Humphrey, P, et al.
Izdano: (1999)

Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
od: Sharpley, A, et al.
Izdano: (1990)

Design of an innovative nanovehicle to enhance brain permeability of a novel 5-HT6 receptor antagonist
od: María Javiera Alvarez-Figueroa, et al.
Izdano: (2024-12-01)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
od: Tijana Bojić, et al.
Izdano: (2022-04-01)

Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation
od: Gonzalo Vera, et al.
Izdano: (2016-08-01)

5-HT3-Receptor Antagonist Inhibits Visceral Pain Differently in Chemical and Mechanical Stimuli in Rats
od: Tomohisa Mori, et al.
Izdano: (2004-01-01)

Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.
od: Gerhard Rammes, et al.
Izdano: (2009-08-01)